BROOKS

Brooks Laboratories Share Price

₹149.26 +3.8 (2.61%)

05 Nov, 2024 17:18

SIP TrendupStart SIP in BROOKS

Start SIP

Performance

  • Low
  • ₹143
  • High
  • ₹150
  • 52 Week Low
  • ₹73
  • 52 Week High
  • ₹186
  • Open Price₹146
  • Previous Close₹145
  • Volume40,385

Investment Returns

  • Over 1 Month + 0.85%
  • Over 3 Month + 40.72%
  • Over 6 Month + 46.19%
  • Over 1 Year + 29.12%
SIP Lightning

Smart Investing Starts Here Start SIP with Brooks Laboratories for Steady Growth!

Brooks Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -22.3
  • PEG Ratio
  • -0.9
  • Market Cap Cr
  • 392
  • P/B Ratio
  • 6
  • Average True Range
  • 7.2
  • EPS
  • 0.6
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.81
  • RSI
  • 56.01
  • MFI
  • 57.34

Brooks Laboratories Financial

IndicatorJun 24Mar 24Dec 23Sep 23Jun 23
Net Sales/Income from operations17.9317.7221.7524.3215.70
Total Income From Operations17.9317.7221.7524.3215.70
P/L Before Interest, Excpt. Items & Tax-0.050.580.821.37-0.36
P/L Before Exceptional Items & Tax-0.210.300.601.18-0.53
P/L After Tax from Ordinary Activities-0.210.300.581.18-0.53
Net Profit/Loss For the Period-0.210.300.581.18-0.53
IndicatorMar 24Mar 23
Revenue From Operations [Gross]79.0153.49
Revenue From Operations [Net]79.0153.49
Total Operating Revenues79.4955.54
Total Revenue80.4455.65
Total Expenses78.8963.84
Profit/Loss Before Tax1.55-8.19
Profit/Loss For The Period1.53-8.19
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity-9.680.56
Net Cash Used In Investing Activity0.18-0.40
Net Cash Used in Finance Activity9.60-0.22
Net Inc/Dec In Cash And Equivalent0.10-0.06
Cash And Equivalent End Of Year0.130.02
IndicatorMar 24Mar 23
Total Share Capital26.2524.70
Total Non-Current Liabilities1.812.62
Total Current Liabilities23.0533.02
Total Capital And Liabilities94.3992.42
Total Non-Current Assets63.3464.82
Total Current Assets31.0527.61
Total Assets94.3992.42
Indicator20242023
EBIT Margin (%)3.01-13.36
Return On Capital Employed (%)3.36-12.49
Return On Equity (%)2.19-14.42
Long Term Debt To Equity (%)0.000.00
Book Value/Share (INR)26.4922.77
IndicatorJun 24Mar 24Dec 23Sep 23Jun 23
Net Sales/Income from operations17.9317.7221.7524.3215.70
Total Income From Operations17.9317.7221.7524.3215.70
P/L Before Interest, Excpt. Items & Tax-0.050.580.821.37-0.36
P/L Before Exceptional Items & Tax-0.210.300.601.18-0.53
P/L After Tax from Ordinary Activities-0.210.300.581.18-0.53
Net Profit/Loss For the Period-0.210.300.581.18-0.53
IndicatorMar 24Mar 23
Revenue From Operations [Gross]79.0163.20
Revenue From Operations [Net]79.0163.20
Total Operating Revenues79.4963.20
Total Revenue80.4463.41
Total Expenses78.8998.83
Profit/Loss Before Tax1.55-35.07
Profit/Loss For The Period1.53-27.74
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity-9.68-14.49
Net Cash Used In Investing Activity0.180.49
Net Cash Used in Finance Activity9.6011.41
Net Inc/Dec In Cash And Equivalent0.10-2.58
Cash And Equivalent End Of Year0.130.02
IndicatorMar 24Mar 23
Total Share Capital26.2524.70
Total Non-Current Liabilities1.812.62
Total Current Liabilities23.0533.02
Total Capital And Liabilities90.45109.60
Total Non-Current Assets59.4081.99
Total Current Assets31.0527.61
Total Assets90.45109.60
Indicator20242023
EBIT Margin (%)3.01-52.59
Return On Capital Employed (%)3.56-43.41
Return On Equity (%)-29.87-28.26
Long Term Debt To Equity (%)0.000.00
Book Value/Share (INR)24.9929.65

Brooks Laboratories Technicals

EMA & SMA

Current Price
₹149.26
+ 3.8 (2.61%)
pointer
  • stock-down_img
  • Bullish Moving Average 16
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹140.02
  • 50 Day
  • ₹135.85
  • 100 Day
  • ₹126.16
  • 200 Day
  • ₹117.90

Resistance and Support

145.02 Pivot Speed
  • R3 158.89
  • R2 154.12
  • R1 149.79
  • S1 140.69
  • S2 135.92
  • S3 131.59

Is Brooks Laboratories Worth Buying?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Brooks Laboratories has an operating revenue of Rs. 81.72 Cr. on a trailing 12-month basis. An annual revenue growth of 27% is outstanding, Pre-tax margin of 2% needs improvement, ROE of -29% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 21% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 11% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 18 which is a POOR score indicating inconsistency in earnings, a RS Rating of 73 which is FAIR indicating the recent price performance, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 32 indicates it belongs to a strong industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Brooks Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-08-14 Quarterly Results
2024-05-18 Audited Results
2024-01-31 Quarterly Results
2024-01-24 Rights & Preferential issue
2023-11-09 Quarterly Results

Brooks Laboratories F&O

Brooks Laboratories Shareholding Pattern

63.59%
3.86%
0.02%
28.54%
3.99%
  • NSE Symbol
  • BROOKS
  • BSE Symbol
  • 533543
  • ISIN
  • INE650L01011

Brooks Laboratories FAQs

Brooks Laboratories share price is ₹149 As on 05 November, 2024 | 17:04

The Market Cap of Brooks Laboratories is ₹391.8 Cr As on 05 November, 2024 | 17:04

The P/E ratio of Brooks Laboratories is -22.3 As on 05 November, 2024 | 17:04

The PB ratio of Brooks Laboratories is 6 As on 05 November, 2024 | 17:04

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form